You are here

  • Home
  • Archive
  • Volume 9, Issue 4
  • Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants

 

Online download statistics by month:

Online download statistics by month: April 2021 to June 2025

AbstractFullPdf
Apr 2021339339157
May 202116216253
Jun 202112312339
Jul 202111511527
Aug 202110410421
Sep 2021767625
Oct 2021868636
Nov 202111011036
Dec 2021838429
Jan 2022606334
Feb 2022747823
Mar 2022647533
Apr 2022707641
May 2022657140
Jun 2022626619
Jul 2022575933
Aug 2022616139
Sep 2022596028
Oct 2022596230
Nov 2022636535
Dec 2022363614
Jan 2023485215
Feb 2023697119
Mar 2023414227
Apr 2023384025
May 2023232414
Jun 2023373717
Jul 2023363617
Aug 2023404222
Sep 202348485
Oct 2023293015
Nov 2023585917
Dec 202314214321
Jan 2024444522
Feb 2024404021
Mar 2024485069
Apr 2024303034
May 2024343528
Jun 2024424219
Jul 2024748336
Aug 2024394415
Sep 2024109112132
Oct 202410110455
Nov 20248710141
Dec 202410210722
Jan 2025707338
Feb 2025858942
Mar 2025656537
Apr 202516216336
May 2025464833
Jun 2025252517
Total374038511703